Showing 1 - 10 of 289
The paper evaluates the German health care reform of 1997, using the individual number of doctor visits as outcome measure and data from the German Socio- Economic Panel for the years 1995-1999. A number of modified count data models allow to estimate the effect of the reform in different parts...
Persistent link: https://www.econbiz.de/10010315477
I consider the problem of evaluating the effect of a health care reform on the demand for doctor visits when the effect is potentially different in different parts of the outcome distribution. Quantile regression is a useful technique for studying such heterogeneous treatment effects. Recent...
Persistent link: https://www.econbiz.de/10010315524
This paper reports on a re-evaluation of the German health care reform of 1997. A previous evaluation found a limited effect of a 4.4 percent reduction of the number of doctor visits in a sample of pharmacy customers. The re-evaluation based on a representative household survey, the German...
Persistent link: https://www.econbiz.de/10010315525
The German health care reform of 1997 provides a natural experiment for evaluating the price sensitivity of demand for physicians' services. As a part of the reform, co-payments for prescription drugs were increased step up to 200%. However, certain groups of people were exempted from the...
Persistent link: https://www.econbiz.de/10010315599
This contribution contains an international comparison of preferences. Using two Discrete Choice Experiments (DCE), it measures willingness to pay for health insurance attributes in Germany and the Netherlands. Since the Dutch DCE was carried out right after the 2006 health reform, which made...
Persistent link: https://www.econbiz.de/10010315539
There is growing interest in discrete-choice experiment (DCE) as a method to elicit consumers' preferences in the health care sector. Increasingly this method is used to determine willingness to pay (WTP) for health-related goods. However, its external validity in the health care domain has not...
Persistent link: https://www.econbiz.de/10010315568
This paper examines how physicians in China respond to a pay-for-performance scheme that mismeasures performance. In 2005, China imposed a policy that penalizes hospitals with high drug sale percentage in the total revenue, with the intent to decrease drug expenditure. Using a unique...
Persistent link: https://www.econbiz.de/10011396831
Prior literature on quality disclosure focuses on whether information provision affects consumer choice. This paper extends this research and explores whether information presentation affects consumer responsiveness in the context of Assisted Reproductive Technology (ART) reports. I find that...
Persistent link: https://www.econbiz.de/10011396834
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...
Persistent link: https://www.econbiz.de/10011663278
I investigate the relationship between physician pay, C-section use, and infant health, using vital statistics data and newly collected data on Medicaid payments to physicians. First, I confirm past results - when Medicaid pays doctors relatively more for C-sections, they perform them more...
Persistent link: https://www.econbiz.de/10012030370